Susan Lessner

Susan Lessner


Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2008 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
SIShinichi Itoh
Shinichi Itoh
HKHa Won Kim
Ha Won Kim
ONOsamu Nakagawa
Osamu Nakagawa
KOKiyoshi Ozumi
Kiyoshi Ozumi
SLSusan Lessner
Susan Lessner
TFTohru Fukai
Tohru Fukai
Copper plays a fundamental role in regulating cell growth. Many types of human cancer tissues have higher copper levels than normal tissues. Copper can also induce gene expression. However, transcription factors that mediate copper-induced cell proliferation have not been identified in mammals. Here we show that antioxidant-1 (Atox1), previously appreciated as a copper chaperone, represents a novel copper-dependent transcription factor that mediates copper-induced cell proliferation. Stimulation of mouse embryonic fibroblasts (MEFs) with copper markedly increased cell proliferation, cyclin D1 expression, and entry into S phase, which were completely abolished in Atox1-/- MEFs. Promoter analysis and EMSA revealed that copper stimulates the Atox1 binding to a previously undescribed cis element in the cyclin D1 promoter. The ChIP assay confirms that copper stimulates Atox1 binding to the DNA in vivo. Transfection of Atox1 fused to the DNA-binding domain of Gal4 demonstrated a copper-dependent transactivation in various cell types, including endothelial and cancer cells. Furthermore, Atox1 translocated to the nucleus in response to copper through its highly conserved C-terminal KKTGK motif and N-terminal copper-binding sites. Finally, the functional role of nuclear Atox1 is demonstrated by the observation that re-expression of nuclear-targeted Atox1 in Atox1-/- MEFs rescued the defective copper-induced cell proliferation. Thus, Atox1 functions as a novel transcription factor that, when activated by copper, undergoes nuclear translocation, DNA binding, and transactivation, thereby contributing to cell proliferation.

3 February 2004 in Circulation
Verified
Journal Article
Closed access
PDF file
JKJaikirshan J. Khatri
Jaikirshan J. Khatri
CJChad Johnson
Chad Johnson
RMRichard Magid
Richard Magid
SLSusan Lessner
Susan Lessner
KLKarine M. Laude
Karine M. Laude
ZGZorina S. Galis
Zorina S. Galis
Background— Although multiple pathological processes have been associated with oxidative stress, the causative relation between oxidative stress and arterial lesion progression remains unclear. Methods and Results— To test the effect of creating arterial wall oxidative stress, we compared progression of mouse carotid lesions induced by flow cessation in the wild-type (WT) versus transgenic mice (Tg p22vsmc ), in which overexpression of p22phox, a critical component of NAD(P)H oxidase was targeted to smooth muscle cell (SMC). Compared with WT mice, arterial lesions grew significantly larger in Tg p22vsmc ( P <0.001) and demonstrated elevated hydrogen peroxide (H 2 O 2 ) and vascular endothelial growth factor (VEGF) levels at all time points examined ( P <0.001, n=4 animals per time point), probably related to increased expression of hypoxia inducible factor (HIF)-1α via SMC oxidative stress in the Tg p22vsmc arteries, both basally (203±12% versus WT, P <0.001, n=3) and after lesion formation. Interestingly, Tg p22vsmc lesions were complicated by extensive neointimal angiogenesis. In vitro experiments confirmed SMCs isolated from Tg p22vsmc to be the source for increased H 2 O 2 , VEGF, and HIF-1α and their capacity to induce angiogenic cord-like structures when cocultured with endothelial cells. The antioxidant ebselen inhibited SMC activities in vitro and intralesion angiogenesis and lesion progression in vivo. Conclusions— We have demonstrated a novel pathway by which oxidative stress can trigger in vivo an angiogenic switch associated with experimental plaque progression and angiogenesis. This pathway may be related to human atheroma progression and destabilization through intraplaque hemorrhage.

6 February 2004 in Circulation Research
Verified
Journal Article
Closed access
PDF file
CJChad Johnson
Chad Johnson
HSHak-Joon Sung
Hak-Joon Sung
SLSusan Lessner
Susan Lessner
MFM. Elizabeth Fini
M. Elizabeth Fini
ZGZorina S. Galis
Zorina S. Galis
Angiogenesis, an essential component of a variety of physiological and pathological processes, offers attractive opportunities for therapeutic regulation. We hypothesized that matrix metalloproteinase-9 genetic deficiency (MMP-9 −/− ) will impair angiogenesis triggered by tissue ischemia, induced experimentally by femoral artery ligation in mice. To investigate the role of MMP-9, we performed a series of biochemical and histological analyses, including zymography, simultaneous detection of perfused capillaries, MMP-9 promoter activity, MMP-9 protein, and macrophages in MMP-9 −/− and wild-type (WT) mice. We found that ischemia resulted in doubling of capillary density in WT and no change in the MMP-9 −/− ischemic tissues, which translated into increased (39%) perfusion capacity only in the WT at 14 days after ligation. We also confirmed that capillaries in the MMP-9 −/− presented significantly ( P <0.05) less points of capillary intersections, interpreted by us as decreased branching. The combined conclusions from simultaneous localizations of MMP-9 expression, capillaries, and macrophages suggested that macrophage MMP-9 participates in capillary branching. Transplantation of WT bone marrow into the MMP-9 −/− , restored capillary branching, further supporting the contribution of bone marrow–derived macrophages in supplying the necessary MMP-9. Our study indicates that angiogenesis triggered by tissue ischemia requires MMP-9, which may be involved in capillary branching, a potential novel role for this MMP that could be exploited to control angiogenesis.

1 June 2002 in The American Journal of Pathology
Verified
Journal Article
Closed access
SLSusan Lessner
Susan Lessner
HPHeather L. Prado
Heather L. Prado
EWEdmund K. Waller
Edmund K. Waller
ZGZorina S. Galis
Zorina S. Galis

2 July 2007 in Journal of Biomedical Materials Research Part A
Verified
Journal Article
Closed access
PDF file
MSM.A. Sutton
M.A. Sutton
XKX. Ke
X. Ke
SLSusan Lessner
Susan Lessner
MGM. Goldbach
M. Goldbach
MYM. Yost
M. Yost
HSH.W. Schreier
H.W. Schreier

1 May 2004 in The American Journal of Pathology
Verified
Journal Article
Closed access
SKSe-Hwa Kim
Se-Hwa Kim
SLSusan Lessner
Susan Lessner
YSYumiko Sakurai
Yumiko Sakurai
ZGZorina S. Galis
Zorina S. Galis